请输入您要查询的百科知识：

　

词条 Gastric inhibitory polypeptide
释义

  1. Synthesis and transport

  2. Functions

  3. Pathology

  4. References

  5. External links

{{Infobox gene}}Gastric inhibitory polypeptide (GIP) or gastroinhibitory peptide, also known as the glucose-dependent insulinotropic peptide, is an inhibiting hormone of the secretin family of hormones.[1] While it is weak inhibitor of gastric acid secretion, its main role is to stimulate insulin secretion.[2]

GIP, along with glucagon-like peptide-1 (GLP-1), belongs to a class of molecules referred to as incretins.[3]

Synthesis and transport

GIP is derived from a 153-amino acid proprotein encoded by the GIP gene and circulates as a biologically active 42-amino acid peptide. It is synthesized by K cells, which are found in the mucosa of the duodenum and the jejunum of the gastrointestinal tract.[4]

Like all endocrine hormones, it is transported by blood.

Gastric inhibitory polypeptide receptors are seven-transmembrane proteins found on beta-cells in the pancreas.

Functions

It has traditionally been named gastrointestinal inhibitory peptide or gastric inhibitory peptide and was found to decrease the secretion of stomach acid[5] to protect the small intestine from acid damage, reduce the rate at which food is transferred through the stomach, and inhibit the GI motility and secretion of acid. However, this is incorrect, as it was discovered that these effects are achieved only with higher-than-normal physiological level, and that these results naturally occur in the body through a similar hormone, secretin.

It is now believed that the function of GIP is to induce insulin secretion, which is stimulated primarily by hyperosmolarity of glucose in the duodenum.[6] After this discovery, some researchers prefer the new name of glucose-dependent insulinotropic peptide, while retaining the acronym "GIP." The amount of insulin secreted is greater when glucose is administered orally than intravenously.[7]

In addition to its role as an incretin GIP is known to inhibit apoptosis of the pancreatic beta cells and to promote their proliferation. It also stimulates glucagon secretion and fat accumulation. GIP receptors are expressed in many organs and tissues including the central nervous system enabling GIP to influence hippocampal memory formation and regulation of appetite and satiety.[8]

GIP recently appeared as a major player in bone remodeling. Researchers at Universities of Angers and Ulster evidenced that genetic ablation of the GIP receptor in mice resulted in profound alterations of bone microarchitecture through modification of the adipokine network.[9] Furthermore, the deficiency in GIP receptors has also been associated in mice with a dramatic decrease in bone quality and a subsequent increase in fracture risk.[10] However, the results obtained by these groups are far from conclusive because their animal models give discordant answers and these works should be analysed very carefully.

Pathology

It has been found that Type 2 diabetics are not responsive to GIP and have lower levels of GIP secretion after a meal when compared to non-diabetics.[11] In research involving knockout mice, it was found that absence of the GIP receptors correlates with resistance to obesity.[12]

References

1. ^{{cite journal | vauthors = Meier JJ, Nauck MA | title = Glucagon-like peptide 1(GLP-1) in biology and pathology | journal = Diabetes/Metabolism Research and Reviews | volume = 21 | issue = 2 | pages = 91–117 | year = 2005 | pmid = 15759282 | doi = 10.1002/dmrr.538 }}
2. ^{{cite journal | vauthors = Pederson RA, McIntosh CH | title = Discovery of gastric inhibitory polypeptide and its subsequent fate: Personal reflections | journal = Journal of Diabetes Investigation | volume = 7 Suppl 1 | issue = | pages = 4–7 | year = 2016 | pmid = 27186348 | pmc = 4854497 | doi = 10.1111/jdi.12480 }}
3. ^{{cite journal | vauthors = Efendic S, Portwood N | title = Overview of incretin hormones | journal = Hormone and Metabolic Research | volume = 36 | issue = 11–12 | pages = 742–6 | year = 2004 | pmid = 15655702 | doi = 10.1055/s-2004-826157 }}
4. ^{{Cite book|title=Physiology|last=Costanzo|first=Linda|publisher=Saunders/Elsevier|year=2014|isbn=9781455708475|location=Philadelphia, PA|pages=337|via=}}
5. ^{{cite journal | vauthors = Kim W, Egan JM | title = The role of incretins in glucose homeostasis and diabetes treatment | journal = Pharmacological Reviews | volume = 60 | issue = 4 | pages = 470–512 | date = Dec 2008 | pmid = 19074620 | pmc = 2696340 | doi = 10.1124/pr.108.000604 }}
6. ^{{cite journal | vauthors = Thorens B | title = Glucagon-like peptide-1 and control of insulin secretion | journal = Diabète & Métabolisme | volume = 21 | issue = 5 | pages = 311–8 | date = Dec 1995 | pmid = 8586147 | doi = }}
7. ^{{cite book | first1 = Walter F. | last1 = Boron | first2 = Emile L. | last2 = Boulpaep | title = Medical physiology: a cellular and molecular approach | year = 2009 | publisher = Saunders/Elsevier | location = Philadelphia, PA | isbn = 9781416031154 | edition = 2nd International | name-list-format = vanc }}
8. ^{{cite journal|doi=10.1111/j.2040-1124.2010.00022.x|pmid=24843404|pmc=4020673|title=GIP and GLP-1, the two incretin hormones: Similarities and differences|journal=Journal of Diabetes Investigation|volume=1|issue=1–2|pages=8–23|year=2010|last1=Seino|first1=Yutaka|last2=Fukushima|first2=Mitsuo|last3=Yabe|first3=Daisuke}}
9. ^{{cite journal | vauthors = Gaudin-Audrain C, Irwin N, Mansur S, Flatt PR, Thorens B, Baslé M, Chappard D, Mabilleau G | title = Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecular bone volume and quality in mice | journal = Bone | volume = 53 | issue = 1 | pages = 221–30 | date = Mar 2013 | pmid = 23220186 | doi = 10.1016/j.bone.2012.11.039 | url = http://eprints.uthm.edu.my/8086/1/Dr._Sity_Aishah.pdf }}
10. ^{{cite journal | vauthors = Mieczkowska A, Irwin N, Flatt PR, Chappard D, Mabilleau G | title = Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality | journal = Bone | volume = 56 | issue = 2 | pages = 337–42 | date = Oct 2013 | pmid = 23851294 | doi = 10.1016/j.bone.2013.07.003 }}
11. ^{{cite journal | vauthors = Skrha J, Hilgertová J, Jarolímková M, Kunešová M, Hill M | title = Meal test for glucose-dependent insulinotropic peptide (GIP) in obese and type 2 diabetic patients | journal = Physiological Research | volume = 59 | issue = 5 | pages = 749–55 | year = 2010 | pmid = 20406045 | doi = }}
12. ^{{cite journal | vauthors = Yamada Y, Seino Y | title = Physiology of GIP--a lesson from GIP receptor knockout mice | journal = Hormone and Metabolic Research | volume = 36 | issue = 11–12 | pages = 771–4 | year = 2004 | pmid = 15655707 | doi = 10.1055/s-2004-826162 }}

External links

  • {{MeshName|Gastric+inhibitory+polypeptide}}
  • {{cite web | first = Michael W. | last = King | name-list-format = vanc | title = Gastrointestinal Hormones and Peptides | url = http://web.indstate.edu/thcme/mwking/peptide-hormones.html#gastrin | date = 16 November 2006 | publisher = Indiana University – Purdue University Indianapolis School of Medicine | archive-url = https://web.archive.org/web/20071206035951/http://web.indstate.edu:80/thcme/mwking/peptide-hormones.html#gastrin |archive-date=6 December 2007 | dead-url = yes }}
{{Hormones}}{{Gastrointestinal physiology}}{{Gastrointestinal hormones}}{{Neuropeptides}}

3 : Gastroenterology|Intestinal hormones|Diabetes
随便看

　

开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。

　

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间：2024/11/12 4:11:27